Exact Mass: 495.1821
Exact Mass Matches: 495.1821
Found 127 metabolites which its exact mass value is equals to given mass value 495.1821
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Morphine dinicotinate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
2,4(1H,3H)-Pyrimidinedione, 3-((2R)-2-amino-2-phenylethyl)-1-((2,6-difluorophenyl)methyl)-5-(2-fluoro-3-methoxyphenyl)-6-methyl-
(9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, methyl ester
2-[(2S*,3R*,4S*)-3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]ethyl pyridine-3-carboxylate|tripterospermumcin A
KT5823
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Cys Asp Lys Met
Cys Asp Met Lys
Cys Lys Asp Met
Cys Lys Met Asp
Cys Met Asp Lys
Cys Met Lys Asp
Cys Asn Pro Tyr
Cys Asn Tyr Pro
Cys Pro Asn Tyr
Cys Pro Tyr Asn
Cys Ser Thr Trp
Cys Ser Trp Thr
Cys Thr Ser Trp
Cys Thr Trp Ser
Cys Trp Ser Thr
Cys Trp Thr Ser
Cys Tyr Asn Pro
Cys Tyr Pro Asn
Asp Cys Lys Met
Asp Cys Met Lys
Asp Lys Cys Met
Asp Lys Met Cys
Asp Met Cys Lys
Asp Met Lys Cys
Lys Cys Asp Met
Lys Cys Met Asp
Lys Asp Cys Met
Lys Asp Met Cys
Lys Met Cys Asp
Lys Met Asp Cys
Met Cys Asp Lys
Met Cys Lys Asp
Met Asp Cys Lys
Met Asp Lys Cys
Met Lys Cys Asp
Met Lys Asp Cys
Met Met Asn Thr
Met Met Gln Ser
Met Met Ser Gln
Met Met Thr Asn
Met Asn Met Thr
Met Asn Thr Met
Met Gln Met Ser
Met Gln Ser Met
Met Ser Met Gln
Met Ser Gln Met
Met Thr Met Asn
Met Thr Asn Met
Asn Cys Pro Tyr
Asn Cys Tyr Pro
Asn Met Met Thr
Asn Met Thr Met
Asn Pro Cys Tyr
Asn Pro Tyr Cys
Asn Thr Met Met
Asn Tyr Cys Pro
Asn Tyr Pro Cys
Pro Cys Asn Tyr
Pro Cys Tyr Asn
Pro Asn Cys Tyr
Pro Asn Tyr Cys
Pro Tyr Cys Asn
Pro Tyr Asn Cys
Gln Met Met Ser
Gln Met Ser Met
Gln Ser Met Met
Ser Cys Thr Trp
Ser Cys Trp Thr
Ser Met Met Gln
Ser Met Gln Met
Ser Gln Met Met
Ser Thr Cys Trp
Ser Thr Trp Cys
Ser Trp Cys Thr
Ser Trp Thr Cys
Thr Cys Ser Trp
Thr Cys Trp Ser
Thr Met Met Asn
Thr Met Asn Met
Thr Asn Met Met
Thr Ser Cys Trp
Thr Ser Trp Cys
Thr Trp Cys Ser
Thr Trp Ser Cys
Trp Cys Ser Thr
Trp Cys Thr Ser
Trp Ser Cys Thr
Trp Ser Thr Cys
Trp Thr Cys Ser
Trp Thr Ser Cys
Tyr Cys Asn Pro
Tyr Cys Pro Asn
Tyr Asn Cys Pro
Tyr Asn Pro Cys
Tyr Pro Cys Asn
Tyr Pro Asn Cys
KT 5823
Nicomorphine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
2,4(1H,3H)-Pyrimidinedione, 3-((2R)-2-amino-2-phenylethyl)-1-((2,6-difluorophenyl)methyl)-5-(2-fluoro-3-methoxyphenyl)-6-methyl-
[4-[2-(4-Methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-(3-thiophenyl)methanone
1-[(2S,3R,6S)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
1-[(2R,3R,6R)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
1-[(2S,3S,6R)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
1-[(2S,3R,6R)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
1-[(2S,3S,6S)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
1-[(2R,3S,6R)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
1-[(2R,3S,6S)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
1-[(2R,3R,6S)-6-[2-(4-cyclohexyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(3,4-dichlorophenyl)urea
Anti-inflammatory agent 35
Anti-inflammatory agent 35 (compound 5a27) is an orally active curcumin analogue with anti-inflammatory activity. Anti-inflammatory agent 35 blocks mitogen-activated protein kinase (MAPK) signaling and p65 nuclear translocation of NF-kB. Anti-inflammatory agent 35 also inhibits yellow neutrophil infiltration and pro-inflammatory cytokine production. Anti-inflammatory agent 35 significantly attenuates lipopolysaccharide (LPS)-induced acute lung injury (ALI) in vivo[1].